-
1
-
-
0030476647
-
506Gln)
-
506Gln). Br J Haemat 1996; 95: 579-586.
-
(1996)
Br J Haemat
, vol.95
, pp. 579-586
-
-
Rees, D.C.1
-
2
-
-
0027965649
-
Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism
-
Dahlback B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-927.
-
(1994)
J Clin Invest
, vol.94
, pp. 923-927
-
-
Dahlback, B.1
-
4
-
-
0031737932
-
Pathophysiology and laboratory testing of heparin-induced thrombocytopenia
-
Chong BH, Eisbacher M. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia. Seminars in Hematology 1998; 35: 3-8.
-
(1998)
Seminars in Hematology
, vol.35
, pp. 3-8
-
-
Chong, B.H.1
Eisbacher, M.2
-
5
-
-
0031962947
-
Donor factor V Leiden mutation and vascular thrombosis following liver transplantation
-
Hirshfield G, Collier JD, Brown K et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transplantation and Surgery 1998; 4: 58-61.
-
(1998)
Liver Transplantation and Surgery
, vol.4
, pp. 58-61
-
-
Hirshfield, G.1
Collier, J.D.2
Brown, K.3
-
6
-
-
0030884671
-
506Q) mutation and risk of thrombosis in renal transplant recipients
-
506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation 1997; 64: 604-607.
-
(1997)
Transplantation
, vol.64
, pp. 604-607
-
-
Irish, A.B.1
Green, F.R.2
Gray, D.W.3
-
7
-
-
0033537469
-
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease
-
Kiechl S, Muigg A, Santer P et al. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation 1999; 99: 614-619.
-
(1999)
Circulation
, vol.99
, pp. 614-619
-
-
Kiechl, S.1
Muigg, A.2
Santer, P.3
-
8
-
-
0031964217
-
Factor V Leiden mutation in a case with ischemic stroke: Which relationship? A case report
-
Orlandi G, Pellegrinetti A, Fioretti C et al. Factor V Leiden mutation in a case with ischemic stroke: Which relationship? A case report. Angiology 1998; 49: 79-82.
-
(1998)
Angiology
, vol.49
, pp. 79-82
-
-
Orlandi, G.1
Pellegrinetti, A.2
Fioretti, C.3
-
9
-
-
0030970663
-
Activated protein C resistance, factor V Leiden and peripheral vascular disease
-
Foley PW, Irvine CD, Standen GR et al. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovasc Surg 1997; 5: 157-160.
-
(1997)
Cardiovasc Surg
, vol.5
, pp. 157-160
-
-
Foley, P.W.1
Irvine, C.D.2
Standen, G.R.3
-
10
-
-
0033029040
-
Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The study of men born in 1913
-
Hansson PO, Eriksson E, Welin L et al. Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The study of men born in 1913. Journal of Internal Medicine 1999; 245: 593-600.
-
(1999)
Journal of Internal Medicine
, vol.245
, pp. 593-600
-
-
Hansson, P.O.1
Eriksson, E.2
Welin, L.3
-
11
-
-
0030667686
-
Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective
-
Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Annals Intern Med 1997; 127: 895-903.
-
(1997)
Annals Intern Med
, vol.127
, pp. 895-903
-
-
Price, D.T.1
Ridker, P.M.2
|